Acumen Pharmaceuticals Inc (NASDAQ: ABOS) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Acumen Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Acumen Pharmaceuticals Inc is $70.27M. A total of 94007.0 shares were traded on the day, compared to an average of 342.50K shares.

In the most recent transaction, Zuga Matt sold 28,902 shares of ABOS for 1.72 per share on Jan 23 ’25. After the transaction, the CFO & Chief Business Officer now owns 231,744 company shares. In a previous transaction on Jan 21 ’25, Zuga Matt sold 4,364 shares at 1.60 per share. ABOS shares that CFO & Chief Business Officer owns now total 260,646.

Among the insiders who sold shares, OConnell Daniel Joseph disposed of 12,619 shares on Jan 21 ’25 at a per-share price of $1.59. This resulted in the Chief Executive Officer holding 667,488 shares of ABOS after the transaction. In another insider transaction, Meisner Derek M sold 3,418 shares at $1.59 per share on Jan 21 ’25. Company shares held by the Chief Legal Officer & Corp Sec now total 161,127.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ABOS has a high of $3.60 and a low of $0.86.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ABOS’s latest balance sheet shows that the firm has $194.24M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $5.15M in liabilities at the time. Its Book Value Per Share was $2.57, while its Total Shareholder’s Equity was $225.18M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABOS is Buy with a score of 5.00.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.